Storage and handling
Other information Do not store above 30 0 C or 86 0 F
No7 Rebalancing Day Fluid Sunscreen SPF 15
- Manufacturer
- Boots Retail USA Inc | The Boots Company PLC | BCM Ltd
- Effective date
- 2009-12-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 22:23:01
Label at a glance#
ProductNo7 Rebalancing Day Fluid Sunscreen SPF 15
Active ingredientOCTINOXATE, AVOBENZONE, ENSULIZOLE
Label structure16 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com
www.boots.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients
Octinoxate (6.0%)
Avobenzone (2.0%)
Ensulizole (2.0%)
OTC - PURPOSE SECTION
Purpose
Sunscreens
Uses
- Provides moderate protection against the adverse effects of the sun
- Higher SPF gives more protection
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
When using this product
- Keep out of eyes. If contact occurs, rinse thoroughly with cold water.
- Avoid direct contact with fabrics.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash or irritation develops and lasts.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help.
INDICATIONS & USAGE SECTION
Directions
- After cleansing, massage over your face and neck, avoiding contact with your eyes.
- Apply evenly at least 15 minutes before sun exposure.
- Reapply as required.
- Not intended for children under the age of 12.
- Not intended for protection while sunbathing.
STORAGE AND HANDLING SECTION
Other information
Do not store above 300C or 860F
INACTIVE INGREDIENT SECTION
Inactive ingredients
Aqua (Water), Glycerin, Cyclopentasiloxane, Alcohol denat., Cyclohexasiloxane, C12-15 alkyl benzoate, Triethanolamine, Dimethicone, Acrylamide/ammonium acrylate copolymer, Cetyl alcohol, Myristyl myristate, C18-36 acid glycol ester, Phenoxyethanol, Lauryl methacrylate/glycol dimethacrylate cross polymer, Polyisobutene, Glyceryl stearate, PEG-100 stearate, Betaine, Parfum (Fragrance), Dimethiconol, Methylparaben, Sodium 2-pyrrolidone-5-carboxylate, Xanthan gum, Ethylparaben, Sodium hyaluronate, Polysorbate 20, Dipropylene glycol, Sorbitol, Tetrasodium EDTA, Serine, Glycine, Glutamic acid, Lysine, BHT, Alanine, Arginine, Threonine, Propylparaben.
OTC - QUESTIONS SECTION
USA/Canada: Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
Balanced Hydration...
Treat your skin to a long cool drink with this deliciously light lotion, created to work in harmony with oily to combination skin without blocking pores.
The revolutionary water-based formula vanishes in to give your skin just the amount of moisture it needs. At the same time, the oil-absorbing micro-sponges work to reduce skin oiliness so you look youthfully radiant, not shiny.
With hyaluronic acid to keep skin hydrated for 24 hours, plus our ultra-light SPF 15 to care and protect.
After 2 weeks 68% of our testers said their skin looked healthier and more radiant.
A little facial everyday...
After cleansing, massage over your face and neck. Apply prior to sun exposure. Avoid direct contact with eyes.
Dermatologically tested.
INFORMATION FOR PATIENTS SECTION
Made in the UK
The Boots Company PLC Nottingham England NG2 3AA
Dist in the USA by Boots Retail USA Inc. Stamford CT06901
DESCRIPTION SECTION
Bottle label
Balanced Hydration...
Treat your skin to a long cool drink with this light fluid, created for oily to combination skin without blocking pores.
The water-based formula gives your skin just the amount of moisture it needs. At the same time, the oil-absorbing micro-sponges work to reduce skin oiliness so you look youthfully radiant, not shiny.
With hyaluronic acid to keep skin hydrated for 24 hours.
After 2 weeks 68% of our testers said their skin looked healthier and more radiant.
A little facial everyday...
After cleansing, massage over your face and neck.
Apply prior to sun exposure.
Avoid direct contact with eyes.
Dermatologically tested.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients:
Octinoxate (6.0%)
Avobenzone (2.0%)
Ensulizole (2.0%)
INFORMATION FOR PATIENTS SECTION
Made in the UK
The Boots Company PLC Nottingham England NG2 3AA.
Dist in the USA by Boots Retail USA Inc. Stamford CT06901
USA/Canada: Questions? 1-866-75-BOOTS
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Carton label
No7
Rebalancing Day Fluid
Oily/Combination
Moisturises, mattifies and balances your skin
Sunscreen SPF 15
Hypo-allergenic
Boots
100ml e 3.3 US Fl. Oz
Rebalancing Day Fluid carton.jpg
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Rebalancing Day Fluid
Oily/Combination
Moisturises and mattifies your skin
Sunscreen SPF 15
Hypo-allergenic
Boots
100ml e 3.3 US Fl. Oz
Rebalancing Day Fluid bottle.jpg
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68472-102-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d887-621f-e053-dbdaa90a74ad | Carton and bottle labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68472-102-01 | No7 Rebalancing Day Fluid Sunscreen SPF 15 | 100 mL in 1 BOTTLE, PUMP | LOTION | 100 | 4 | |
| 68472-102-01 | No7 Rebalancing Day Fluid Sunscreen SPF 15 | 1 in 1 CARTON | LOTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 4 | |
| ENSULIZOLE | ACTIVE INGREDIENT | 9YQ9DI1W42 | 4 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 4 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 4 | |
| ENSULIZOLE | ACTIVE MOIETY | 9YQ9DI1W42 | 4 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 4 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 4 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 4 | |
| BETAINE | INACTIVE INGREDIENT | 3SCV180C9W | 4 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 4 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 4 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 4 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 4 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 4 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 4 | |
| GLUTAMIC ACID | INACTIVE INGREDIENT | 3KX376GY7L | 4 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 4 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 4 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 4 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 4 | |
| LYSINE | INACTIVE INGREDIENT | K3Z4F929H6 | 4 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 4 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 4 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 4 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | 4 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 4 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 4 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 4 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 4 | |
| THREONINE | INACTIVE INGREDIENT | 2ZD004190S | 4 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 4 |
Products#
Every source-derived product name is available through these pages.
- No7 Rebalancing Day Fluid Sunscreen SPF 15
- Octinoxate and Avobenzone and Ensulizole
- OCTINOXATE
- AVOBENZONE
- ENSULIZOLE
- WATER
- GLYCERIN
- CYCLOMETHICONE 5
- CYCLOMETHICONE 6
- TROLAMINE
- DIMETHICONE
- CETYL ALCOHOL
- PHENOXYETHANOL
- GLYCERYL MONOSTEARATE
- BETAINE
- METHYLPARABEN
- SODIUM PYRROLIDONE CARBOXYLATE
- XANTHAN GUM
- HYALURONATE SODIUM
- ETHYLPARABEN
- POLYSORBATE 20
- SORBITOL
- SERINE
- GLYCINE
- GLUTAMIC ACID
- LYSINE
- BUTYLATED HYDROXYTOLUENE
- ALANINE
- ARGININE
- THREONINE
- PROLINE
- PROPYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68472-102 | 68472-102-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUPPOSITORY / RECTAL | 35 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | 5 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, EXTENDED RELEASE / ORAL | 132 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / TOPICAL | 3 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | 1808 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RECTAL | 0.02 %w/v | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOAP / TOPICAL | 0.02 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET / ORAL | 50 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| SORBITOL | SORBITOL | 506T60A25R | SPRAY / NASAL | 49 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / AURICULAR (OTIC) | NA | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SPRAY / NASAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / TOPICAL | 0.16 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / VAGINAL | 2 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAVENOUS | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 6240 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE / ORAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 0.02 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2a56fde5-475d-4449-8c84-9ac076774c9b | cecd6954-4470-466f-95ca-29d22d1511fe | 2009-12-14 | Warnings | 2a56fde5-475d-4449-8c84-9ac076774c9b cecd6954-4470-466f-95ca-29d22d1511fe |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.